ML19270E565: Difference between revisions

Exubrion Therapeutics, Inc Public Meeting
	ML19207A501
Person / Time
Issue date:	07/26/2019
From:	; Office of Nuclear Material Safety and Safeguards
To:	;
References
	PMNS20190727
	Download: ML19207A501 (2)
	v • d • e

Summary of July 29, 2019, Public Meeting with Exubrion Therapeutics to Discuss Its Veterinary Uses of Sn-117m
	ML19270E566
Person / Time
Issue date:	09/30/2019
From:	Irene Wu; NRC/NMSS/DMSST
To:	Christian Einberg; NRC/NMSS/DMSST
	IRENE WU MSST
References
	Download: ML19270E566 (5)
	v • d • e

Summary of July 29, 2019, Public Meeting with Exubrion Therapeutics to Discuss Its Veterinary Uses of Sn-117m
Date released: 10/08/2019	Download: ML19270E565
	v • d • e

Latest revision as of 09:34, 23 January 2020

Exubrion - Canine Synovetin Oa Treatment Public Dose Limitation Presentation to Us to NRC
Person / Time
ML19206A448
Issue date:	07/24/2019
From:	Exubrion Therapeutics
To:	Office of Nuclear Material Safety and Safeguards
Howe, Donna-Beth
References
Download: ML19206A448 (35)
v • d • e

@@ Line 20: / Line 20: @@
 | number = ML19207A501
 | issue date = 07/26/2019
-| title = Summary of July 29, 2019, Public Meeting with Exubrion Therapeutics to Discuss Its Veterinary Uses of Sn-117m
+| title = Exubrion Therapeutics, Inc Public Meeting
 | author name =
 | author affiliation = NRC/NMSS
@@ Line 34: / Line 34: @@
 | number = ML19206A448
 | issue date = 07/24/2019
-| title = Summary of July 29, 2019, Public Meeting with Exubrion Therapeutics to Discuss Its Veterinary Uses of Sn-117m
+| title = Exubrion - Canine Synovetin Oa Treatment Public Dose Limitation Presentation to Us to NRC
 | author name =
 | author affiliation = Exubrion Therapeutics